Last reviewed · How we verify

NCT06380842

Organ Dysfunction Change in Acute Necrotizing Pancreatitis Patients With Sepsis After Open Necrosectomy

Recruiting now Last updated 23 September 2025
What this trial tests

trial testing Necrotizing Pancreatitis patients' organ dysfunction progression in Necrotizing Pancreatitis in 200 participants. Currently enrolling.

Timeline
15 June 2024
Primary endpoint
30 December 2026
30 December 2026

Quick facts

Lead sponsorChunling Jiang
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date15 June 2024
Primary completion30 December 2026
Estimated completion30 December 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Chunling Jiang

Who can join

18 and older, any sex, with Necrotizing Pancreatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to characterize organ dysfunction change in acute necrotizing pancreatitis patients with sepsis after open necrosectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Chunling Jiang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06380842.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing